Deccan Healthcar

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE452W01019
  • NSEID:
  • BSEID: 542248
INR
12.69
-0.31 (-2.38%)
BSENSE

Aug 10, 03:30 PM

BSE+NSE Vol: 1257

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003095,
    "name": "Deccan Healthcar",
    "stock_name": "Deccan Healthcar",
    "full_name": "Deccan Health Care Ltd",
    "name_url": "stocks-analysis/deccan-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.69",
    "chg": -0.31,
    "chgp": "-2.38%",
    "dir": -1,
    "prev_price": "13.00",
    "mcapval": "33.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542248,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE452W01019",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "08:27 AM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": 1257,
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/deccan-healthcar-1003095-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Deccan Health Care Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-is-rated-sell-4130048",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DeccanHealthCar_mojoScore_4130048.png",
        "date": "2026-07-31 10:11:06",
        "description": "Deccan Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Deccan Health Care Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-is-rated-sell-4093403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DeccanHealthCar_mojoScore_4093403.png",
        "date": "2026-07-08 10:10:56",
        "description": "Deccan Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Deccan Health Care Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-is-rated-sell-4062997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeccanHealthCar_mojoScore_4062997.png",
        "date": "2026-06-19 10:11:29",
        "description": "Deccan Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Deccan Health Care Declines 2.72%: Valuation Shift Amid Mixed Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-declines-272-valuation-shift-amid-mixed-weekly-performance-4051906",
        "imagepath": "",
        "date": "2026-06-13 16:03:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Q4 FY26 results reveal plunging profitability despite revenue growth</p>\n                    <p><strong>3 June:</strong> Valuation upgraded to very attractive amid challenging returns</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.12.50, down 2.72% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.12.50</div><div class=\"stat-change negative\">-2.72%</div></div>\n                  ..."
      },
      {
        "title": "Deccan Health Care Ltd Valuation Shifts to Very Attractive Amidst Challenging Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-ltd-valuation-shifts-to-very-attractive-amidst-challenging-returns-4032801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeccanHealthCar_valuationdot_4032801.png",
        "date": "2026-06-03 08:02:04",
        "description": "Deccan Health Care Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive price range, driven by a marked decline in its price-to-earnings and price-to-book value ratios. This repositioning comes amid a challenging market backdrop and a micro-cap status that continues to weigh on investor sentiment despite recent positive price movements."
      },
      {
        "title": "Are Deccan Health Care Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-deccan-health-care-ltd-latest-results-good-or-bad-4028141",
        "imagepath": "",
        "date": "2026-06-01 19:29:41",
        "description": "Deccan Health Care Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by notable revenue growth juxtaposed against significant profitability challenges. The company reported a net sales figure of ₹20.98 crores, reflecting a quarter-on-quarter growth of 20.64%, which is a positive development compared to the previous quarter's decline. However, this revenue increase did not translate into improved profitability, as net profit fell sharply by 67.00% to ₹0.33 crores from ₹1.00 crore in Q3 FY26.\n\nThe operating margin also contracted considerably, dropping from 9.95% in Q3 to 4.24% in Q4, indicating operational difficulties that may stem from either cost pressures or aggressive pricing strategies aimed at driving sales volume. Similarly, the PAT margin experienced a decline from 5.75% to 1.57%, further underscoring the strain on profitability despite the uptick in rev..."
      },
      {
        "title": "Deccan Health Care Q4 FY26: Profitability Plunges Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/deccan-health-care-q4-fy26-profitability-plunges-despite-revenue-growth-4026781",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeccanHealthCar_quaterlyResult_4026781.png",
        "date": "2026-06-01 12:25:42",
        "description": "Deccan Health Care Limited, a micro-cap healthcare products company specialising in nutraceutical, cosmeceutical and ayurveda products, reported a challenging Q4 FY26 with net profit declining 67.00% quarter-on-quarter to ₹0.33 crores despite revenue growing 20.64% to ₹20.98 crores. The ₹32.00 crore market capitalisation company saw its stock trade at ₹12.80, down 43.36% over the past year and significantly underperforming both the Sensex and its healthcare services sector peers."
      },
      {
        "title": "Deccan Health Care Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3998402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeccanHealthCar_mojoScore_3998402.png",
        "date": "2026-05-19 08:56:38",
        "description": "Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services micro-cap, with a current market price of ₹12.33, continues to underperform the broader market but shows signs of stabilisation in its technical trend, prompting a reassessment of its outlook."
      },
      {
        "title": "Deccan Health Care Ltd Downgraded to Strong Sell Amid Technical Weakness and Long-Term Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-long-term-underperformance-3988915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeccanHealthCar_mojoScore_3988915.png",
        "date": "2026-05-13 08:37:35",
        "description": "Deccan Health Care Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 12 May 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results and rising promoter confidence, the stock’s overall outlook has worsened due to bearish technical trends, underwhelming long-term returns, and valuation concerns within the healthcare services sector."
      }
    ],
    "total": 176,
    "sid": "1003095",
    "stock_news_url": "https://www.marketsmojo.com/news/deccan-health-care-1003095"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30Th 2026.",
      "datetime": "06-Aug-2026",
      "details": "Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30th 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "27-Jul-2026",
      "details": "Scrutinizer Report and Voting Results",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "24-Jul-2026",
      "details": "PROCEEDINGS OF EGM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Deccan Health Care Declines 2.72%: Valuation Shift Amid Mixed Weekly Performance

2026-06-13 16:03:20

Key Events This Week

1 June: Q4 FY26 results reveal plunging profitability despite revenue growth

3 June: Valuation upgraded to very attractive amid challenging returns

5 June: Week closes at Rs.12.50, down 2.72% for the week

stock-recommendationAnnouncement

Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30Th 2026.

06-Aug-2026 | Source : BSE

Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30th 2026.

Shareholder Meeting / Postal Ballot-Scrutinizers Report

27-Jul-2026 | Source : BSE

Scrutinizer Report and Voting Results

Shareholder Meeting / Postal Ballot-Outcome of EGM

24-Jul-2026 | Source : BSE

PROCEEDINGS OF EGM

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

14 Aug 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available